Selected research
Market Analysis & Forecast
Global Biorepository Services Market Analysis and Forecast 2026-2032
Market perspective
The global Biorepository Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Biorepository Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Biorepository Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Biorepository Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Biorepository Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Biorepository Services include Azenta, EPL Archives (VWR), Q2 Lab Solutions, Medpace Labs, Thermo Fisher Scientific, Clinigen, Precision Stability Storage, Precision for Medicine and Kryosphere, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Biorepository Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Biorepository Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Biorepository Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biorepository Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biorepository Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biorepository Services revenue, projected growth trends, production technology, application and end-user industry.
Biorepository Services Segment by Company
Azenta
EPL Archives (VWR)
Q2 Lab Solutions
Medpace Labs
Thermo Fisher Scientific
Clinigen
Precision Stability Storage
Precision for Medicine
Kryosphere
Cryoport Inc
Masy BioServices (Alcami)
SciSafe (BioLife Solutions)
Cenetron (Versiti Clinical Trials)
Vigilant Bioservices
CellCarta
BioArkive
Tescor
Birka BioStorag
Shanghai Biochip Co
Albetra
Biorepository Services Segment by Type
Room Temperature Storage
Refrigerated Storage
Frozen Storage
Ultra Low Temperature Storage
Liquid Nitrogen Storage
Others
Biorepository Services Segment by Application
Life Sciences
Hospital
Research Institutions
Chemical Industry
Others
Biorepository Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biorepository Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biorepository Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biorepository Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Biorepository Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Biorepository Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biorepository Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Room Temperature Storage
- Refrigerated Storage
- Frozen Storage
- Ultra Low Temperature Storage
- Liquid Nitrogen Storage
- Others
Applications
- Life Sciences
- Hospital
- Research Institutions
- Chemical Industry
- Others
Companies covered
- Azenta
- EPL Archives (VWR)
- Q2 Lab Solutions
- Medpace Labs
- Thermo Fisher Scientific
- Clinigen
- Precision Stability Storage
- Precision for Medicine
- Kryosphere
- Cryoport Inc
- Masy BioServices (Alcami)
- SciSafe (BioLife Solutions)
- Cenetron (Versiti Clinical Trials)
- Vigilant Bioservices
- CellCarta
- BioArkive
- Tescor
- Birka BioStorag
- Shanghai Biochip Co
- Albetra
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Biorepository Services Market by Type
- 1.2.1 Global Biorepository Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Room Temperature Storage
- 1.2.3 Refrigerated Storage
- 1.2.4 Frozen Storage
- 1.2.5 Ultra Low Temperature Storage
- 1.2.6 Liquid Nitrogen Storage
- 1.2.7 Others
- 1.3 Biorepository Services Market by Application
- 1.3.1 Global Biorepository Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Life Sciences
- 1.3.3 Hospital
- 1.3.4 Research Institutions
- 1.3.5 Chemical Industry
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Biorepository Services Market Dynamics
- 2.1 Biorepository Services Industry Trends
- 2.2 Biorepository Services Industry Drivers
- 2.3 Biorepository Services Industry Opportunities and Challenges
- 2.4 Biorepository Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Biorepository Services Market Perspective (2021-2032)
- 3.2 Global Biorepository Services Growth Trends by Region
- 3.2.1 Global Biorepository Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Biorepository Services Market Size by Region (2021-2026)
- 3.2.3 Global Biorepository Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Biorepository Services Revenue by Players
- 4.1.1 Global Biorepository Services Revenue by Players (2021-2026)
- 4.1.2 Global Biorepository Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Biorepository Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Biorepository Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Biorepository Services Key Players Headquarters & Area Served
- 4.4 Global Biorepository Services Players, Product Type & Application
- 4.5 Global Biorepository Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Biorepository Services Market CR5 and HHI
- 4.6.3 2025 Biorepository Services Tier 1, Tier 2, and Tier 3
5 Biorepository Services Market Size by Type
- 5.1 Global Biorepository Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Biorepository Services Revenue by Type (2021-2032)
- 5.3 Global Biorepository Services Revenue Market Share by Type (2021-2032)
6 Biorepository Services Market Size by Application
- 6.1 Global Biorepository Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Biorepository Services Revenue by Application (2021-2032)
- 6.3 Global Biorepository Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Azenta
- 7.1.1 Azenta Company Information
- 7.1.2 Azenta Business Overview
- 7.1.3 Azenta Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.1.4 Azenta Biorepository Services Product Portfolio
- 7.1.5 Azenta Recent Developments
- 7.2 EPL Archives (VWR)
- 7.2.1 EPL Archives (VWR) Company Information
- 7.2.2 EPL Archives (VWR) Business Overview
- 7.2.3 EPL Archives (VWR) Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.2.4 EPL Archives (VWR) Biorepository Services Product Portfolio
- 7.2.5 EPL Archives (VWR) Recent Developments
- 7.3 Q2 Lab Solutions
- 7.3.1 Q2 Lab Solutions Company Information
- 7.3.2 Q2 Lab Solutions Business Overview
- 7.3.3 Q2 Lab Solutions Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.3.4 Q2 Lab Solutions Biorepository Services Product Portfolio
- 7.3.5 Q2 Lab Solutions Recent Developments
- 7.4 Medpace Labs
- 7.4.1 Medpace Labs Company Information
- 7.4.2 Medpace Labs Business Overview
- 7.4.3 Medpace Labs Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.4.4 Medpace Labs Biorepository Services Product Portfolio
- 7.4.5 Medpace Labs Recent Developments
- 7.5 Thermo Fisher Scientific
- 7.5.1 Thermo Fisher Scientific Company Information
- 7.5.2 Thermo Fisher Scientific Business Overview
- 7.5.3 Thermo Fisher Scientific Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.5.4 Thermo Fisher Scientific Biorepository Services Product Portfolio
- 7.5.5 Thermo Fisher Scientific Recent Developments
- 7.6 Clinigen
- 7.6.1 Clinigen Company Information
- 7.6.2 Clinigen Business Overview
- 7.6.3 Clinigen Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.6.4 Clinigen Biorepository Services Product Portfolio
- 7.6.5 Clinigen Recent Developments
- 7.7 Precision Stability Storage
- 7.7.1 Precision Stability Storage Company Information
- 7.7.2 Precision Stability Storage Business Overview
- 7.7.3 Precision Stability Storage Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.7.4 Precision Stability Storage Biorepository Services Product Portfolio
- 7.7.5 Precision Stability Storage Recent Developments
- 7.8 Precision for Medicine
- 7.8.1 Precision for Medicine Company Information
- 7.8.2 Precision for Medicine Business Overview
- 7.8.3 Precision for Medicine Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.8.4 Precision for Medicine Biorepository Services Product Portfolio
- 7.8.5 Precision for Medicine Recent Developments
- 7.9 Kryosphere
- 7.9.1 Kryosphere Company Information
- 7.9.2 Kryosphere Business Overview
- 7.9.3 Kryosphere Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.9.4 Kryosphere Biorepository Services Product Portfolio
- 7.9.5 Kryosphere Recent Developments
- 7.10 Cryoport Inc
- 7.10.1 Cryoport Inc Company Information
- 7.10.2 Cryoport Inc Business Overview
- 7.10.3 Cryoport Inc Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.10.4 Cryoport Inc Biorepository Services Product Portfolio
- 7.10.5 Cryoport Inc Recent Developments
- 7.11 Masy BioServices (Alcami)
- 7.11.1 Masy BioServices (Alcami) Company Information
- 7.11.2 Masy BioServices (Alcami) Business Overview
- 7.11.3 Masy BioServices (Alcami) Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.11.4 Masy BioServices (Alcami) Biorepository Services Product Portfolio
- 7.11.5 Masy BioServices (Alcami) Recent Developments
- 7.12 SciSafe (BioLife Solutions)
- 7.12.1 SciSafe (BioLife Solutions) Company Information
- 7.12.2 SciSafe (BioLife Solutions) Business Overview
- 7.12.3 SciSafe (BioLife Solutions) Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.12.4 SciSafe (BioLife Solutions) Biorepository Services Product Portfolio
- 7.12.5 SciSafe (BioLife Solutions) Recent Developments
- 7.13 Cenetron (Versiti Clinical Trials)
- 7.13.1 Cenetron (Versiti Clinical Trials) Company Information
- 7.13.2 Cenetron (Versiti Clinical Trials) Business Overview
- 7.13.3 Cenetron (Versiti Clinical Trials) Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.13.4 Cenetron (Versiti Clinical Trials) Biorepository Services Product Portfolio
- 7.13.5 Cenetron (Versiti Clinical Trials) Recent Developments
- 7.14 Vigilant Bioservices
- 7.14.1 Vigilant Bioservices Company Information
- 7.14.2 Vigilant Bioservices Business Overview
- 7.14.3 Vigilant Bioservices Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.14.4 Vigilant Bioservices Biorepository Services Product Portfolio
- 7.14.5 Vigilant Bioservices Recent Developments
- 7.15 CellCarta
- 7.15.1 CellCarta Company Information
- 7.15.2 CellCarta Business Overview
- 7.15.3 CellCarta Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.15.4 CellCarta Biorepository Services Product Portfolio
- 7.15.5 CellCarta Recent Developments
- 7.16 BioArkive
- 7.16.1 BioArkive Company Information
- 7.16.2 BioArkive Business Overview
- 7.16.3 BioArkive Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.16.4 BioArkive Biorepository Services Product Portfolio
- 7.16.5 BioArkive Recent Developments
- 7.17 Tescor
- 7.17.1 Tescor Company Information
- 7.17.2 Tescor Business Overview
- 7.17.3 Tescor Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.17.4 Tescor Biorepository Services Product Portfolio
- 7.17.5 Tescor Recent Developments
- 7.18 Birka BioStorag
- 7.18.1 Birka BioStorag Company Information
- 7.18.2 Birka BioStorag Business Overview
- 7.18.3 Birka BioStorag Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.18.4 Birka BioStorag Biorepository Services Product Portfolio
- 7.18.5 Birka BioStorag Recent Developments
- 7.19 Shanghai Biochip Co
- 7.19.1 Shanghai Biochip Co Company Information
- 7.19.2 Shanghai Biochip Co Business Overview
- 7.19.3 Shanghai Biochip Co Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.19.4 Shanghai Biochip Co Biorepository Services Product Portfolio
- 7.19.5 Shanghai Biochip Co Recent Developments
- 7.20 Albetra
- 7.20.1 Albetra Company Information
- 7.20.2 Albetra Business Overview
- 7.20.3 Albetra Biorepository Services Revenue and Gross Margin (2021-2026)
- 7.20.4 Albetra Biorepository Services Product Portfolio
- 7.20.5 Albetra Recent Developments
8 North America
- 8.1 North America Biorepository Services Revenue (2021-2032)
- 8.2 North America Biorepository Services Revenue by Type (2021-2032)
- 8.2.1 North America Biorepository Services Revenue by Type (2021-2026)
- 8.2.2 North America Biorepository Services Revenue by Type (2027-2032)
- 8.3 North America Biorepository Services Revenue Share by Type (2021-2032)
- 8.4 North America Biorepository Services Revenue by Application (2021-2032)
- 8.4.1 North America Biorepository Services Revenue by Application (2021-2026)
- 8.4.2 North America Biorepository Services Revenue by Application (2027-2032)
- 8.5 North America Biorepository Services Revenue Share by Application (2021-2032)
- 8.6 North America Biorepository Services Revenue by Country
- 8.6.1 North America Biorepository Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Biorepository Services Revenue by Country (2021-2026)
- 8.6.3 North America Biorepository Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Biorepository Services Revenue (2021-2032)
- 9.2 Europe Biorepository Services Revenue by Type (2021-2032)
- 9.2.1 Europe Biorepository Services Revenue by Type (2021-2026)
- 9.2.2 Europe Biorepository Services Revenue by Type (2027-2032)
- 9.3 Europe Biorepository Services Revenue Share by Type (2021-2032)
- 9.4 Europe Biorepository Services Revenue by Application (2021-2032)
- 9.4.1 Europe Biorepository Services Revenue by Application (2021-2026)
- 9.4.2 Europe Biorepository Services Revenue by Application (2027-2032)
- 9.5 Europe Biorepository Services Revenue Share by Application (2021-2032)
- 9.6 Europe Biorepository Services Revenue by Country
- 9.6.1 Europe Biorepository Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Biorepository Services Revenue by Country (2021-2026)
- 9.6.3 Europe Biorepository Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Biorepository Services Revenue (2021-2032)
- 10.2 China Biorepository Services Revenue by Type (2021-2032)
- 10.2.1 China Biorepository Services Revenue by Type (2021-2026)
- 10.2.2 China Biorepository Services Revenue by Type (2027-2032)
- 10.3 China Biorepository Services Revenue Share by Type (2021-2032)
- 10.4 China Biorepository Services Revenue by Application (2021-2032)
- 10.4.1 China Biorepository Services Revenue by Application (2021-2026)
- 10.4.2 China Biorepository Services Revenue by Application (2027-2032)
- 10.5 China Biorepository Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Biorepository Services Revenue (2021-2032)
- 11.2 Asia Biorepository Services Revenue by Type (2021-2032)
- 11.2.1 Asia Biorepository Services Revenue by Type (2021-2026)
- 11.2.2 Asia Biorepository Services Revenue by Type (2027-2032)
- 11.3 Asia Biorepository Services Revenue Share by Type (2021-2032)
- 11.4 Asia Biorepository Services Revenue by Application (2021-2032)
- 11.4.1 Asia Biorepository Services Revenue by Application (2021-2026)
- 11.4.2 Asia Biorepository Services Revenue by Application (2027-2032)
- 11.5 Asia Biorepository Services Revenue Share by Application (2021-2032)
- 11.6 Asia Biorepository Services Revenue by Country
- 11.6.1 Asia Biorepository Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Biorepository Services Revenue by Country (2021-2026)
- 11.6.3 Asia Biorepository Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Biorepository Services Revenue (2021-2032)
- 12.2 SAMEA Biorepository Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Biorepository Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Biorepository Services Revenue by Type (2027-2032)
- 12.3 SAMEA Biorepository Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Biorepository Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Biorepository Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Biorepository Services Revenue by Application (2027-2032)
- 12.5 SAMEA Biorepository Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Biorepository Services Revenue by Country
- 12.6.1 SAMEA Biorepository Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Biorepository Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Biorepository Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst